WSTAM
CDMO

Wilbanks Smith & Thomas Asset Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-5,000
Closed -$34K – 1357
2018
Q3 		$34K Buy
+5,000
New +$29.6K ﹤0.01% 771

Other funds holding CDMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

Wilbanks Smith & Thomas Asset Management's CDMO Position: Q4 2018 in Review

Wilbanks Smith & Thomas Asset Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2018, closing a stake of 5,000 shares — an estimated $34K sold.

Wilbanks Smith & Thomas Asset Management first reported a position in CDMO in Q3 2018 and held it in 1 quarter. The position peaked at $34K in Q3 2018. 101 funds tracked by Wall St. Rank hold CDMO as of Q4 2018.

  • Wilbanks Smith & Thomas Asset Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Wilbanks Smith & Thomas Asset Management sold 5,000 Avid Bioservices, Inc. Common Stock shares in Q4 2018, an estimated $34K.
  • Wilbanks Smith & Thomas Asset Management first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2018 and held it in 1 quarter.
  • Wilbanks Smith & Thomas Asset Management's Avid Bioservices, Inc. Common Stock position peaked at $34K in Q3 2018.
  • 101 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2018.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q4 2018, filed 8 Feb 2019.